Patrick Wood

Stock Analyst at Morgan Stanley

(0)
# 3703
Out of 5,271 analysts
81
Total ratings
40.74%
Success rate
-0.68%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
PROCEPT BioRobotics
Maintains: Overweight
105 95
60.6 56.77% 2 Feb 26, 2025
DexCom
Maintains: Equal-Weight
75 82
85.94 -4.58% 7 Feb 14, 2025
Edwards Lifesciences
Maintains: Equal-Weight
70 75
71.41 5.03% 8 Feb 12, 2025
Boston Scientific
Maintains: Overweight
100 120
104.8 14.5% 5 Feb 6, 2025
Cooper Companies
Maintains: Equal-Weight
104 102
91.64 11.31% 5 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
45 45
20.75 116.87% 3 Dec 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
120
109.6 9.49% 3 Dec 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
19
15.88 19.65% 6 Dec 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
60 73
80.14 -8.91% 3 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
234 317
272.76 16.22% 5 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
18 10
9.51 5.15% 2 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
104 145
69.43 108.84% 1 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
65 85
94.03 -9.6% 3 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
50 37
16.38 125.89% 2 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
39 30
34.85 -13.92% 3 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
285 335
n/a n/a 6 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
74 86
86.44 -0.51% 5 Feb 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
225 215
222.3 -3.28% 3 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
310 280
228.3 22.65% 3 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
n/a
n/a n/a 3 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
36
26.96 33.53% 1 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 2 Dec 11, 2017